Connect
MJA
MJA

Bevacizumab and hereditary haemorrhagic telangiectasia

Ross P Cruikshank and Boris W Chern
Med J Aust 2011; 194 (6): 324-325.
Published online: 21 March 2011

To the Editor: Hereditary haemorrhagic telangiectasia (HHT) or Osler–Weber–Rendu syndrome manifests as vascular dysplasia involving the nose, skin, lung, brain and gastrointestinal tract. It is an inherited disorder manifesting as unbalanced angiogenesis.1

  • Ross P Cruikshank
  • Boris W Chern

  • Redcliffe Hospital, Brisbane, QLD.

Correspondence: rosscruikshank@yahoo.com

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.